JPRN-UMIN000024865招募中未知
Insulin Degludeg / Insulin Aspart BID injection therapy versus GLP-1 analogue Liraglutide and Insulin Deguldec combination therapy in Tochigi - IDEAL Trial
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who have experienced severe diabeticketosis, diabetic coma, or past history of pre-coma prior to 6 months Patients with severe infections, severe injury or perioperative state. Female patients who have pregnancy or possibilty of pregnancy, or are under lactation Patients who had past history of hypersensitivity or allergic reaction to insulin degludec, aspart or liraglutide Patients with severe liver or renal dysfunction.
研究者
相似试验
进行中（未招募）
1 期
Basal and pre-meal insulin versus standard therapy for the inpatient manegement of type 2 diabetes: The IDA2 studyType 2 diabetesMedDRA version: 19.0Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861EUCTR2016-002910-38-DKHvidovre University Hospital100
进行中（未招募）
1 期
DUAL™VII - Insulin degludec/liraglutide (IDegLira) vs. basal-bolus therapyDiabetes Mellitus, Type 2MedDRA version: 18.0Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861EUCTR2014-003621-18-FRovo Nordisk A/S506
进行中（未招募）
1 期
DUAL™VII - Insulin degludec/liraglutide (IDegLira) vs. basal-bolus therapyDiabetes Mellitus, Type 2EUCTR2014-003621-18-SKovo Nordisk A/S506
进行中（未招募）
1 期
DUAL™VII - Insulin degludec/liraglutide (IDegLira) vs. basal-bolus therapyDiabetes Mellitus, Type 2EUCTR2014-003621-18-CZovo Nordisk A/S500
进行中（未招募）
1 期
DUAL™VII - Insulin degludec/liraglutide (IDegLira) vs. basal-bolus therapyDiabetes Mellitus, Type 2MedDRA version: 18.0Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861EUCTR2014-003621-18-GRovo Nordisk A/S500